Mental health issues for long-COVID patients require deeper study

Embargoed until: Publicly released: 2022-06-30 01:00

International

Image by Peggy und Marco Lachmann-Anke from Pixabay

Long-COVID symptoms such as cognitive impairment, sleep difficulties, depression, post-traumatic stress, and substance use disorders are in need of more research, according to a literature review looking at the neuropsychiatric symptoms associated with COVID-19. Despite difficulties in estimating the overall prevalence of symptoms, the most commonly reported neurologic symptoms in hospitalised patients with severe COVID-19 are fatigue in 33%, sleep abnormalities in 29%, headache in 23%, and loss of taste and smell in 18%. The researchers say that more research is needed, but the people at highest risk of long-COVID seem to be those with more severe COVID-19 disease, especially those requiring hospitalisation.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page

Journal/
conference: JAMA Psychiatry

Research:Paper

Organisation/s: New York University, USA

Funder: Both authors receive funding as co-investigators/faculty at the NYU Grossman School of Medicine for the RECOVER initiative (OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core). Dr Frontera receives funding for the following COVID-19–related grants from these NIH institutes: National Institute of Neurological Disorders and Stroke (3U24NS11384401S1), National Heart, Lung, and Blood Institute (1OT2HL161847-01), and National Institute on Aging (3P30AG066512-01).

Media Contact/s

Contact details are only visible to registered journalists.